Time: Wednesday, February 17th, 12 o’clock
Place: on zoom
Speaker: Professor Jan Terje Andersen, Department of Pharmacology, the Faculty of Medicine, UIO
Title: Design of biologics with better performance
In the project entitled "A Novel Biomarker for Antibody Drug Conjugates" Weyergang and her team seeks to develop a diagnostic tool for better stratification of patients to novel targeted therapeutics including antibody drug conjugates.
SPARK is a Life Science`s innovation program build to increase the success rate of projects with high potential impact, addressing critical unmet needs. Project teams admitted to SPARK will be educated and advised on relevant processes for commercialization of their idea. They will also receive financial support (up to 500 000 NOK per year- maximum two years based on the accomplishment of milesones).